ClinicalTrials.gg
Not yet recruitingNCT07902154VR for MIUpdated Oct 28, 2026

Using Virtual Reality to Augment Brief Interventions for Heavy Drinking Young Adults

An interventional study of Virtual Reality experience and Brief motivational intervention in Alcohol Misuse, sponsored by Brown University. Not yet recruiting. Open to participants aged 18 Years to 34 Years. Per ClinicalTrials.gov, last updated 2026-10-28.

Sponsored by Brown University · Not applicable, Interventional, and Treatment

Updated Oct 28, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
18 Years to 34 Years
Sex
All
01

Study summary

The overarching goal of this research is to explore whether VR might be used to augment brief motivational interviewing (BMI) techniques among heavy drinking young adults (age 18-34) and to test the preliminary efficacy of the VR experience when used within the BMI workflow of a typical counseling session.

02

Conditions studied

  • Alcohol Misuse

Keywords

  • virtual reality
  • alcohol misuse
  • alcohol problems
  • brief interventions
  • counseling
03

In context

Alcohol-Related Disorders

156 studies on the registry are indexed under Alcohol-Related Disorders; 23 are open to participants now.

This study's planned enrollment of 120 is above the median of 101 across 131 interventional studies indexed under Alcohol-Related Disorders.

Browse Alcohol-Related Disorders studies →

Lead sponsor

Brown University is the lead sponsor of 290 studies on the registry; 40 are open to participants now.

Of its 26 completed or terminated interventional studies of FDA-regulated products, 19 (73%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 34 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18-34 years old
  • Report hazardous alcohol use in the past month, as defined by NIAAA guidelines as having had 5 or more drinks on a single occasion for men or 4 or more drinks for women, OR an average of 14 or more drinks in an average week for men or 7 or more drinks on an average week for women
  • Speak and read English fluently
  • Have been referred to the University of Alabama's Collegiate Recovery and Intervention Services (CRIS) for intervention after having received an alcohol-related infraction, injury, arrest, or other problem.

Exclusion criteria

Exclusion criteria:

  • Being at risk for or having a history of complicated alcohol withdrawal, as defined by having a seizure or seeing, hearing, or feeling things that were not really there at a time when they stopped, cut down, or went without drinking
  • Currently receiving treatment for any substance use disorder outside of CRIS
  • Screening positive for another drug use disorder, as assessed by a score of 3 or more on the Drug Abuse Screening Test
  • Have severe mental illness, defined by currently being under the care of a mental health professional for schizophrenia, bipolar disorder, severe depression, or another serious mental health condition
  • Having a history of significant motion sickness, as defined by a total score of 10 or more on the Simulator Sickness Questionnaire
  • Having a history of seizures or a diagnosis of epilepsy or other seizure disorder
  • Having been told by a doctor or other healthcare professional that they should not use devices with bright lights or a lot of visual motion, such as video games, virtual reality glasses, or certain movies, for health-related reasons
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
120 participants (estimated)

Study arms

  • Active comparator
    Brief motivational intervention

    All participants will receive a standard, two-session brief motivational intervention that will involve personalized normative feedback, techniques intended to help explore and resolve ambivalence about drinking, and potential options for change. Each session will last approximately 60 minutes.

    Behavioral: Brief motivational intervention

  • Experimental
    Brief motivational intervention plus the Fresh Start VR experience

    Participants assigned to this condition will receive the same standard two-session brief motivational intervention as in the control group, except the counselor will offer clients the opportunity to use the Fresh Start VR experience as one way of helping them explore and resolve their ambivalence about their drinking.

    Device: Virtual Reality experience · Behavioral: Brief motivational intervention

Interventions

  • DeviceVirtual Reality experience

    The Fresh Start VR experience is intended to help clients reflect on important life priorities and goals and whether their current drinking patterns help facilitate or are an obstacle to those goals.

  • BehavioralBrief motivational intervention

    Brief motivational intervention is a standard, two-session brief motivational intervention that will involve personalized normative feedback, techniques intended to help explore and resolve ambivalence about drinking, and potential options for change. Each session will last approximately 60 minutes.

06

What researchers measure

Primary outcomes

  1. Adoption: percentage of participants who agree to use VR when offered in counseling

    Adoption of VR will be assessed by calculating the percentage of participants assigned to the VR condition who agree to use VR when offered by a counselor during a counseling session.

    Time frame: During the intervention session (at Baseline)

  2. Tolerability: percentage of participants who discontinue VR after starting

    Tolerability will be assessed by calculating the percentage of participants assigned to the VR condition who discontinue using VR after starting to use it.

    Time frame: During the intervention session (at Baseline)

  3. Feasibility: total score on the Feasibility of Intervention Measure

    Feasibility of using VR within brief alcohol counseling sessions will be assessed using the Feasibility of Intervention Measure, a 4-item measure that assesses items such as "Using VR in counseling sessions seems doable." Each item is assessed on a 5-point scale from 1 (completely disagree) to 5 (completely agree). Each participant's total score on the FIM will serve as the primary outcome and will be compared across groups.

    Time frame: Immediately following the intervention session (at Baseline)

  4. Acceptability: total score on the Acceptability of Intervention Measure

    Acceptability of using VR within brief alcohol counseling sessions will be assessed using the Acceptability of Intervention Measure (AIM), a 4-item measure that assesses items such as "Using VR in counseling sessions is appealing to me." Each item is assessed on a 5-point scale from 1 (completely disagree) to 5 (completely agree). Each participant's total score on the AIM will serve as the primary outcome and will be compared across groups.

    Time frame: Immediately following the intervention session (at Baseline)

  5. Satisfaction: total score on the Client Satisfaction Scale 8 (CSQ-8)

    Satisfaction with counseling will be assessed using the Client Satisfaction Questionnaire (CSQ-8), an 8-item measure that assesses items such as "How would you rate the quality of service you have received?" Each item is rated on a 4-point scale, but the response options vary by item (e.g., item 1 ranges from 1 \[poor\] to 4 \[excellent\]). Each participant's total score on the CSQ-8 will serve as the primary outcome and will be compared across groups.

    Time frame: Immediately following the intervention session (at Baseline)

Secondary outcomes

  1. Average drinks per drinking day: The average number of drinks consumed per drinking day over the previous 28 days, as assessed by online Timeline Followback (TLFB) assessment

    An online version of the Timeline Followback will assess drinking days and the number of standard drinks consumed each day over the previous 28 days at baseline, and months 1, 2, 3, and 6 after baseline. At each follow-up, the average number of drinks participants consumed on occasions when they drank will be calculated and compared across groups.

    Time frame: Baseline, 1 month, 2 months, 3 months, and 6 months

  2. Heavy episodic drinking days: Total number of days on which participants reported drinking 4+ drinks (for women) or 5+ drinks (for men) over the previous 28 days, as assessed by online Timeline Followback (TLFB) assessment

    An online version of the Timeline Followback will assess drinking days and the number of standard drinks consumed each day over the previous 28 days at baseline, and months 1, 2, 3, and 6 after baseline. At each follow-up, we will calculate the total number of days on which participants reported drinking 4+ drinks (for women) or 5+ drinks (for men) on a single day and compare them across groups.

    Time frame: Baseline, 1 month, 2 months, 3 months, and 6 months

  3. Alcohol-related problems: Total number of alcohol-related problems in the past 28 days as assessed by the Brief Young Adult Alcohol Consequences Questionnaire (BYAACQ)

    Alcohol-related consequences will be assessed using the Brief Young Adult Alcohol Consequences Questionnaire (B-YAACQ), a 24-item measure that assesses items such as "I have had a hangover (headache, sick stomach) the morning after I had been drinking." Each item is assessed as 0 (no) or 1 (yes). Each participant's total count of problems reported will be compared across groups.

    Time frame: Baseline, 1 month, 2 months, 3 months, and 6 months

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Yes — Data on key outcomes, including both primary outcomes (adoption, tolerability, feasibility, acceptability) and secondary, preliminary efficacy outcomes (average drinks per drinking days, total count of heavy episodic days, and total count of alcohol-related problems) will be shared with the NIAAA Data Archive, in alignment with NIH and NIAAA policy. Only data from participants who specifically consent to having their data archived during the informed consent process will be shared.

Supporting information: Study protocol, Statistical analysis plan

Time frame: Data will be shared by December of 2030 and will be available in perpetuity.

Access criteria: Investigators providing an acceptable purpose for use to the NIAAA Data Archive will be able to access the data.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jan 2027; primary completion for Dec 2029, 35 months later.

Of 49 non-industry interventional studies with no phase under Alcohol-Related Disorders, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 44. This study's planned 35 months is above that.

Counting every sponsor, half of 49 studies reached it within 30 months; a quarter within 17 and three quarters within 44.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 2, 2026
First posted
Oct 28, 2026
StartEst.
Jan 2027
Primary completionEst.
Dec 2029
CompletionEst.
Jun 2030
Last update
Oct 28, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 28, 2026
Show all 1 update
  1. Oct 28, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07902154
Lead sponsor
Brown University
Responsible party
Tyler Wray (Associate Professor, Brown University) — Principal investigator
First posted
Oct 28, 2026
Start date
Jan 2027 (estimated)
Primary completion
Dec 2029 (estimated)
Completion
Jun 2030 (estimated)
Last update
Oct 28, 2026

Study contacts

Kristina Project Manager
Contact
kristina_morreale@brown.edu401-863-3610
401-863-3610

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion